UChicagoCancerCenter

Dr. Marina Garassino recently presented about the early promise of AI tools across drug discovery and clinical decision-making in lung cancer. onclive.com/view/ai-tools-… @OncLive @marinagarassino #lcsm

New podcast episode just dropped 💥: Learn how AI and machine learning are transforming cancer research and care. ow.ly/aLUV50Zuqr8 @lab_pearson

This year's Jonas Center Cellular Therapy Symposium is coming up!! 🗓️ When? September 25, 2026 🗺️ Where? UChicago's campus 🤔 Questions/registration? jonascentersymposium.com See you in September!

👀 #Tobacco use causes nearly 3️⃣0️⃣% of all cancer-related deaths. Findings from @JCO_ASCO detailed how a proactive, opt-out #smoking cessation program targeted patients with #cancer who smoked and helped them get referrals for counseling and medication. vist.ly/5aih5

🚬Dr. Andrea C. King @UChicago said it should be “standard of care” for patients with #cancer who smoke to get smoking-cessation assistance. She spoke with @GoHealio about a program that systematically reaches out to current smokers to help them quit. 🔗 bit.ly/4p7miA9

How Do I Know if a Clinical Trial Is Right for Me? A comic explaining the risks and benefits of participating in a cancer clinical trial, translated for a Polish-speaking audience.

Zhang et al., published a new article in @JCOPO_ASCO highlighting the potential of cfDNA-derived 5-hydroxymethycytosine signatures as a noninvasive prognostic biomarker in newly diagnosed multiple myeloma. @UChicagoRADS @UChicagoHemOnc @UChicagoPHS ow.ly/4ekN50ZtAg9

Highlights From ASCO 2026: Lymphoma vumedi.com/video/highligh… via @vumedi

Drs. Ackroyd & Lee recently published in the International Journal of Gynecologic Cancer, highlighting the importance of shared decision-making and patient-centered care in advanced and recurrent uterine cancer. Read ➡️ bit.ly/3T0nLwd

Meet Sarah Shubeck, MD, MS, breast surgical oncologist committed to compassionate, patient-centered care for individuals with breast cancer. Her research advances value and quality in breast surgical care. #FollowFriday @UChicagoBreast @spshubeck ow.ly/oufn50ZsmQP

Research from @UChicago suggests that an engineered bacteria strain may be a powerful approach for improving treatment response in pancreatic cancer. @UChicago_Micro @UChicagoRadOnc @UCCancerCenter 🔗 Read more: pme.uchicago.edu/news-events/ne…

🔥Hot off the press: @UChicago researchers show reduced pancreatic tumor growth using engineered Bifidobacterium to produce super mutant IL-2 that activates tumor-fighting T cells. @rweichselbaum @mark_mimee @UChicagoPME @UChicago_Micro @UChicagoRadOnc uchicagomedicine.org/forefront/canc…

We’re hiring a Clinical Research Coordinator 2 at UChicago Hematology/Oncology to support wearable and digital health cancer studies in older adults. Apply: uchicago.wd5.myworkdayjobs.com/External/job/C…

Two recent projects focused on TIL therapy: 🎙️ A convo with TIL experts for ASTCT Talks @DrBetofMDPhD @slgoff_SB @ASTCT 📄 Our new review in Cancer on the history and future of TIL therapy @UCCancerCenter Podcast: open.spotify.com/episode/5lAoIA… Paper: acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

congrats to @Anand_88_Patel @myeloidmalig who are co-authors on a manuscript looking at pulmonary HTN in patients with MPNs! link.springer.com/article/10.100…

Thank you to the South Side residents who came out to last week's community meeting on the AbbVie Foundation Cancer Pavilion, opening April 2027. UChicago Medicine leaders shared how the pavilion will bring screening, treatment, infusion care and wellness support under one roof.

new paper featuring @DrWendyStock as co-author on a paper focused on guideline-based care in AYAs with ALL! pubmed.ncbi.nlm.nih.gov/42474359/

Dr. Peter O'Donnell is quoted in this @SurvivorNetTeam story about a newly approved bladder cancer treatment. survivornet.com/articles/new-a…

Meet Ardaman Shergill, MD, (@ArdamanShergil1), a medical oncologist specializing in gastrointestinal cancers. Follow her for updates on targeted therapies for GI cancers, including novel treatments aimed at the KRAS pathway. @UChicagoGI @UChicagoMed ow.ly/kcpe50ZjMxn

UChicago Medicine’s freestanding cancer center to open April 2027 hpherald.com/evening_digest… via @HydeParkHerald